Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Tada

Showing results (391-400 of 407) with videos related to

Pageof 41
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|January 4, 2012
Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosisT Toyama, Y Asano, T Takahashi, et al.
Internal Medicine (Tokyo, Japan)|August 6, 1999
Labeled carcinoembryonic antigen antibodies excitable by infrared rays: a novel diagnostic method for micro cancers in the digestive tractN Muguruma, S Ito, T Bando, et al.
The British Journal of Dermatology|May 1, 2012
Augmented production of soluble CD93 in patients with systemic sclerosis and clinical association with severity of skin sclerosisK Yanaba, Y Asano, S Noda, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 1, 2012
Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosisT Taniguchi, Y Asano, K Akamata, et al.
Cancer Treatment Reviews|July 28, 2020
Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic reviewM J M Uijen, G Lassche, A C H van Engen-van Grunsven, et al.
Clinical and Experimental Rheumatology|March 30, 2010
Tacrolimus is effective for lupus nephritis patients with persistent proteinuriaA Uchino, H Tsukamoto, H Nakashima, et al.
Dermatology and Therapy|December 19, 2023
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)A Pinter, A Costanzo, S Khattri, et al.
Atherosclerosis|June 1, 1996
Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cellsT Tamagaki, S Sawada, H Imamura, et al.
The British Journal of Dermatology|December 31, 2019
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trialA Blauvelt, K Papp, A Gottlieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2022
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2A P Fernandez, E Dauden, S Gerdes, et al.
Pageof 41

Showing results (391-400 of 407) with videos related to

Sort By:
Pageof 41
Journal of the European Academy of Dermatology and Venereology : JEADV|January 4, 2012
Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosisT Toyama, Y Asano, T Takahashi, et al.
Internal Medicine (Tokyo, Japan)|August 6, 1999
Labeled carcinoembryonic antigen antibodies excitable by infrared rays: a novel diagnostic method for micro cancers in the digestive tractN Muguruma, S Ito, T Bando, et al.
The British Journal of Dermatology|May 1, 2012
Augmented production of soluble CD93 in patients with systemic sclerosis and clinical association with severity of skin sclerosisK Yanaba, Y Asano, S Noda, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 1, 2012
Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosisT Taniguchi, Y Asano, K Akamata, et al.
Cancer Treatment Reviews|July 28, 2020
Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic reviewM J M Uijen, G Lassche, A C H van Engen-van Grunsven, et al.
Clinical and Experimental Rheumatology|March 30, 2010
Tacrolimus is effective for lupus nephritis patients with persistent proteinuriaA Uchino, H Tsukamoto, H Nakashima, et al.
Dermatology and Therapy|December 19, 2023
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)A Pinter, A Costanzo, S Khattri, et al.
Atherosclerosis|June 1, 1996
Effects of high-density lipoproteins on intracellular pH and proliferation of human vascular endothelial cellsT Tamagaki, S Sawada, H Imamura, et al.
The British Journal of Dermatology|December 31, 2019
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trialA Blauvelt, K Papp, A Gottlieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2022
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2A P Fernandez, E Dauden, S Gerdes, et al.
Pageof 41